A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Schones, Dustin E., Ph.D. Laboratory Bookmark and Share

Laboratory of Dustin E. Schones, Ph.D.

Our lab is generally interested in the role of chromatin in gene regulation and how other regulatory elements interact with chromatin. In addition to this, we are interested in how genetic variation interacts with epigenetic variation in the development of diseases such as diabetes and cancer. We utilize an integrative approach, combining experimental and computational methods, to study these problems.
 
One area of the lab is focused on the basic biology of mechanisms responsible for regulating chromatin architecture. We have identified characteristic chromatin patterns at functional regulatory regions of the genome, including promoter and distal enhancer regions. We are furthermore tracking changes in nucleosome positions along various lineage commitment pathways and investigating what mechanisms are responsible for regulating chromatin changes as well as how the changes in chromatin influence other regulatory events.
 
In addition, we are exploring the interaction of epigenetic and genetic variation in mouse models of cancer and diabetes. Genome-wide profiles of chromatin modifications, transcription factor binding, transcript production and genetic variation all provide one-dimensional views of genome regulation. To truly understand the regulatory networks involved in normal development – and how these networks are disrupted in disease progression – we must begin to integrate these data sets. Our results indicate that changes in chromatin accessibility cooperate with genetic variation to influence phenotypes. We are developing methods to integrate genotype, gene expression and chromatin information in prediction of phenotype. Furthermore, we are using these data from model systems to evaluate the potential of obtaining relevant genotype information from chromatin accessibility profiling. We anticipate these methods will be of practical use for personalized medicine in the clinic.
 
 
For more information on Dr. Schones, please click here.

Dustin Schones, Ph.D. Lab Members

Lab Members:
 
Beisi Xu, Ph.D.
Postdoctoral Fellow
626-256-4673, ext. 63300
beixu@coh.org
 
Juan Du
Grad Student
626-256-4673 ext. 64521
jdu@coh.org
 
Candi Trac, M.S.
Research Associate II
626-256-4673, ext. 64521
ctrac@coh.org

Schones, Dustin E., Ph.D. Laboratory

Laboratory of Dustin E. Schones, Ph.D.

Our lab is generally interested in the role of chromatin in gene regulation and how other regulatory elements interact with chromatin. In addition to this, we are interested in how genetic variation interacts with epigenetic variation in the development of diseases such as diabetes and cancer. We utilize an integrative approach, combining experimental and computational methods, to study these problems.
 
One area of the lab is focused on the basic biology of mechanisms responsible for regulating chromatin architecture. We have identified characteristic chromatin patterns at functional regulatory regions of the genome, including promoter and distal enhancer regions. We are furthermore tracking changes in nucleosome positions along various lineage commitment pathways and investigating what mechanisms are responsible for regulating chromatin changes as well as how the changes in chromatin influence other regulatory events.
 
In addition, we are exploring the interaction of epigenetic and genetic variation in mouse models of cancer and diabetes. Genome-wide profiles of chromatin modifications, transcription factor binding, transcript production and genetic variation all provide one-dimensional views of genome regulation. To truly understand the regulatory networks involved in normal development – and how these networks are disrupted in disease progression – we must begin to integrate these data sets. Our results indicate that changes in chromatin accessibility cooperate with genetic variation to influence phenotypes. We are developing methods to integrate genotype, gene expression and chromatin information in prediction of phenotype. Furthermore, we are using these data from model systems to evaluate the potential of obtaining relevant genotype information from chromatin accessibility profiling. We anticipate these methods will be of practical use for personalized medicine in the clinic.
 
 
For more information on Dr. Schones, please click here.

Lab Members

Dustin Schones, Ph.D. Lab Members

Lab Members:
 
Beisi Xu, Ph.D.
Postdoctoral Fellow
626-256-4673, ext. 63300
beixu@coh.org
 
Juan Du
Grad Student
626-256-4673 ext. 64521
jdu@coh.org
 
Candi Trac, M.S.
Research Associate II
626-256-4673, ext. 64521
ctrac@coh.org
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • Cancer treatments have improved over the years, but one potential source of treatments and cures remains largely untapped: nature. Blueberries, cinnamon, xinfeng, grape seed (and skin) extract, mushrooms, barberry and pomegranates all contain compounds with the potential to treat or prevent cancer. Scientists a...
  • In the U.S., there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostate and lung, according to the American Cancer Society. Each year, 5 million people are treated for skin cancer. Here, Hans Schoellhammer, M.D., assistant clinical professor at City of Hope | Ant...
  • As public health experts know, health improvement starts in the community. Now, City of Hope  has been recognized for its efforts to improve the lives of residents of its own community. The institution will receive funding from the Institute for Healthcare Improvement  to support promising community-based work ...
  • For almost four decades, blood cancer survivors who received bone marrow, or stem cell, transplants have returned to City of Hope to celebrate life, second chances and science. The first reunion, in 1976, was a small affair: spaghetti for a single patient, his brother who served as his donor and those who took ...
  • Chemotherapy is an often-essential component of cancer treatment, attacking cells that divide quickly and helping stop cancer’s advance. But the very characteristics that make chemotherapy effective against cancer also can make it toxic to healthy cells, leading to side effects such as hair loss, nausea, ...
  • When you want to understand how to enhance the patient experience, go straight to the source: The patients. Patients and their families offer unique perspectives on care and services and can provide valuable insights about what is working well and what is not. That’s why City of Hope turns to them for advice. S...
  • Take it from City of Hope researchers: Medical science isn’t just for scientists, but something the whole family can enjoy. From 1 to 4 p.m. on Saturday, May 16, the institution will offer a variety of educational and fun-filled science and healthy living activities at its second Community Science Festiva...
  • Attention, parents! Only a few serious sunburns can increase a child’s ultimate risk of skin cancer. Further, some studies suggest that ultraviolet (UV) exposure before the age of 10 is the most important factor for melanoma risk. Here skin cancer expert Jae Jung, M.D., Ph.D., assistant professor in the D...
  • Esophagheal cancer may not be on many people’s radar, but heartburn probably is. The latter can ultimately lead to the former. More formally referred to as gastroesophageal reflux, heartburn occurs when stomach content makes its way back up into the esophagus, causing stomach acid to come into contact with the ...
  • Many City of Hope cancer patients are opening their hearts to an electronic confidante. The tablet-based program, called SupportScreen, prompts them to share deeply personal concerns about their health — and helps jump-start their care. “We’ve found that people will reveal more to a machine than to a person. Te...
  • Older adults, by far, represent the largest population of cancer patients globally. With the median age of U.S. citizens projected to increase sharply in the next few years, the incidence of cancer is expected to rise higher, as well. City of Hope is at the forefront of geriatric cancer care, and an important n...
  • Treatment of cancers of the head and neck requires not just skill, but consummate skill. After all, consider their location: the lip, mouth, tongue, throat and nasal cavity – and that’s just for starters. Such treatment can include chemotherapy and radiation, but surgery is often the primary approach, wit...
  • On a spring day in 2013, 10-year-old Jackie Garcia of Whittier, California, noticed a lump in her jaw. Her mother suspected it was a minor problem, perhaps due to a fall, but made an appointment with a pediatrician, just to be on the safe side. “He thought it was an infection that was dental-related, and told [...
  • Creative expression comes in two very different forms for Robert Kang, M.D., M.P.H., assistant clinical professor of otolaryngology and a plastic surgeon at City of Hope. In his day job, Kang performs surgeries on patients with complex head and neck cancers, specializing in advanced facial reconstructions and r...
  • Surgery for head and neck cancers is unarguably complex, requiring extremely controlled movements and exceptional training. “Given where we are operating, our primary concern is maintaining speaking, swallowing and breathing,” said Ellie Maghami, M.D., chief of head and neck surgery, who recently teamed with Ro...